Skip to main content
. 2020 Aug 21;12(4):303–310. doi: 10.5114/jcb.2020.98108

Table 9.

Comparison of papers regarding eye plaque brachytherapy used to treat large size tumors to COMS trials

Trial Study n Time Local recurrence Metastasis mortality Overall survival
COMS medium 125I plaque vs. enucleation 1,317 5 years 10.3% 9% 81%
12 years 21% 57%
COMS large EBRT before enucleation vs. enucleation alone 1,003 5 years N/A 28% 57%
10 years N/A 60% 40%
Shields et al. 125I, 106Ru, 60Co, 192Ir 354 5 years 9% 30%
10 years 13% 55%
Puusaari et al. 125I 121 5 years 6% 35% 62%